Feb 14, 2024 / 01:00PM GMT
Operator
Ladies and gentlemen, good day, and welcome to Q3 FY24 earnings conference call of Gland Pharma Limited. (Operator Instructions) Please note that this conference is being recorded. And I now hand the conference over to Mr. Ankit Gupta. Thank you and over to you, sir.
Ankit Gupta - Gland Pharma Limited - Head - Investments, Strategy & Investor Relations
Thank you, Sagar. Good evening, everyone. We welcome you to Gland Pharma earnings conference call for Q3 FY24. My name is Ankit and I drive the investments, M&A, and corporate strategy for Gland. I have Mr. Srinivas Sadu, MD and CEO, and Mr. Ravi Mitra, CFO, to discuss business performance and financial highlights for the quarter. We will begin this call with the business highlights by Mr. Sadu, followed by a financial overview by Mr. Ravi.
Before we proceed, please note the Safe Harbor statement that we have on the press release. Some of the statements that we make today will be forward-looking and will be based on the current estimates that management has. These statements must be viewed in
Q3 2024 Gland Pharma Ltd Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers